drugset / Trial / NCT00976105

Effects of Repeat Dosing of GSK1521498

NCT00976105

Phase 1 Completed 49 enrolled GlaxoSmithKline
RandomizedParallel-groupDouble-blindTreatment

Summary

The overall purpose of this study is to see whether the drug is safe and well tolerated when given to overweight or obese but otherwise healthy volunteers for 10 days. Up to 4 groups of people will be given the drug at variable strengths. The blood levels of the drug will be measured and the effects on mood and cognition (the mental processes involved in awareness, learning and judgement) will be assesed.

Timeline

Start
2009-09-22
Primary completion
2010-03-09
Completion
2010-03-09

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK1521498 Small molecule 10 mg
Comparator Zolpidem Small molecule 10 mg

Indications